INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo TOTONIK ELIXIR
SCHEDULING STATUS:
Not scheduled

PROPRIETARY NAME
(and dosage form):

TOTONIK ELIXIR

COMPOSITION:
Active ingredients per 10 mL
Thiamine hydrochloride         5 mg
Riboflavine - Sodium Phosphate         2 mg
Pyridoxine hydrochloride         0,5 mg
Nicotinamide         5 mg
Cyanocobalamin         5 mcg
Pantothenol         2 mg
Tocopherol acetate         5 mg
Potassium glycerophosphate         100 mg
Caffeine         30 mg
Ferrous sulphate         15 mg
Preservative: Nipasept         0,024%
Alcohol 96%         12,2% v/v

PHARMACOLOGICAL CLASSIFICATION:
33 Tonics

PHARMACOLOGICAL ACTION:
Totonik is a nutritional supplement.

INDICATIONS:
Totonik is recommended for postoperative, convalescent and debilitated patients.

CONTRA-INDICATIONS:
In the recommended dosage there are no contra-indications and the possibility of any toxic effects are remote.

WARNINGS:
Keep out of reach of children.

DOSAGE AND DIRECTIONS FOR USE:
Adults:                2 medicine measure (10 mL) three times per day before meals.
Children (4-15 years): 1-2 medicine measure (5-10 mL) three times per day before meals.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
None - provided that the recommended dosage is adhered to. This product contains alcohol & sugar, therefore Diabetics should exercise caution.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Alcohol induced drowsiness. Treatment should be symptomatic and supportive.

IDENTIFICATION:
Reddish-brown mixture.

PRESENTATION:
Amber glass bottles in 200 mL.

STORAGE INSTRUCTIONS:
Store below 25°C and protect from light.
KEEP OUT OF REACH OF CHILDREN.

REGISTRATION NUMBER:
F/33/5

NAME AND BUSINESS ADDRESS OF APPLICANT:
Pharmaceutical Enterprises (Pty) Ltd
Howard Studios, Howard Drive, Pinelands 7405

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
12/01/99

Updated on this site: March 2004
Source: Pharmaceutical Industry

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2004